Ludovic Samalin

Summary

Affiliation: CHU de Clermont-Ferrand
Country: France

Publications

  1. doi request reprint Residual depressive symptoms, sleep disturbance and perceived cognitive impairment as determinants of functioning in patients with bipolar disorder
    Ludovic Samalin
    CHU Clermont Ferrand, Department of Psychiatry, EA 7280, University of Auvergne, Clermont Ferrand, France Bipolar Disorder Unit, Institute of Neuroscience, Hospital Clinic, University of Barcelona, IDIBAPS, CIBERSAM, Barcelona, Catalonia, Spain Fondation FondaMental, Creteil, France Electronic address
    J Affect Disord 210:280-286. 2017
  2. pmc Clinical Decision-Making in the Treatment of Schizophrenia: Focus on Long-Acting Injectable Antipsychotics
    Ludovic Samalin
    Centre Hospitalier et Universitaire, Department of Psychiatry, University of Auvergne, EA 7280, 63000 Clermont Ferrand, France
    Int J Mol Sci 17:. 2016
  3. doi request reprint Attitudes toward antipsychotic medications as a useful feature in exploring medication non-adherence in schizophrenia
    Ludovic Samalin
    CHU Clermont Ferrand, University of Auvergne, EA 7280, Clermont Ferrand, France Fondation FondaMental, Creteil, France Electronic address
    Schizophr Res 178:1-5. 2016
  4. doi request reprint [Aripiprazole long-acting for the maintenance treatment of schizophrenia.]
    L Samalin
    Service de Psychiatrie B, CHU de Clermont Ferrand, EA 7280, Universite d Auvergne, 58, rue Montalembert, 63000 Clermont Ferrand, France Electronic address
    Encephale 40:487-494. 2014
  5. pmc Patient perspectives on use of long-acting antipsychotics in bipolar disorder: focus on risperidone injection
    L Samalin
    Centre Hospitalier Universitaire, Clermont Ferrand, France
    Patient Prefer Adherence 4:325-34. 2010
  6. doi request reprint Residual symptoms and functional performance in a large sample of euthymic bipolar patients in France (the OPTHYMUM study)
    Ludovic Samalin
    CHU Clermont Ferrand, EA7280, Auvergne University, Clermont Ferrand, France Electronic address
    J Affect Disord 159:94-102. 2014
  7. pmc Guidelines for the use and management of long-acting injectable antipsychotics in serious mental illness
    Pierre Michel Llorca
    CHU Clermont Ferrand, EA 7280, Clermont Ferrand University, Clermont Ferrand, France
    BMC Psychiatry 13:340. 2013
  8. doi request reprint [French Society for Biological Psychiatry and Neuropsychopharmacology task force: Formal Consensus for the prescription of depot antipsychotics]
    L Samalin
    CHU Clermont Ferrand, EA U7280, Universite d Auvergne, Clermont Ferrand, France Electronic address
    Encephale 39:189-203. 2013
  9. doi request reprint Clinicians' attitudes toward the use of long-acting injectable antipsychotics
    Ludovic Samalin
    Department of Psychiatry B, University of Auvergne, Clermont Ferrand, France
    J Nerv Ment Dis 201:553-9. 2013
  10. doi request reprint Methodological differences between pharmacological treatment guidelines for bipolar disorder: what to do for the clinicians?
    Ludovic Samalin
    Department of Adult Psychiatry B, CHU Clermont Ferrand, 58 rue Montalembert, 63000 Clermont Ferrand, France
    Compr Psychiatry 54:309-20. 2013

Collaborators

Detail Information

Publications28

  1. doi request reprint Residual depressive symptoms, sleep disturbance and perceived cognitive impairment as determinants of functioning in patients with bipolar disorder
    Ludovic Samalin
    CHU Clermont Ferrand, Department of Psychiatry, EA 7280, University of Auvergne, Clermont Ferrand, France Bipolar Disorder Unit, Institute of Neuroscience, Hospital Clinic, University of Barcelona, IDIBAPS, CIBERSAM, Barcelona, Catalonia, Spain Fondation FondaMental, Creteil, France Electronic address
    J Affect Disord 210:280-286. 2017
    ..The study aimed to analyse the relationship between residual depressive symptoms, sleep disturbances and self-reported cognitive impairment as determinants of psychosocial functioning in a large sample of euthymic BD patients...
  2. pmc Clinical Decision-Making in the Treatment of Schizophrenia: Focus on Long-Acting Injectable Antipsychotics
    Ludovic Samalin
    Centre Hospitalier et Universitaire, Department of Psychiatry, University of Auvergne, EA 7280, 63000 Clermont Ferrand, France
    Int J Mol Sci 17:. 2016
    ..The more clinicians follow schizophrenic patients, the more they use LAI antipsychotics. The development of specialized programs with top specialists should lead to better use of LAI antipsychotics in the treatment of schizophrenia...
  3. doi request reprint Attitudes toward antipsychotic medications as a useful feature in exploring medication non-adherence in schizophrenia
    Ludovic Samalin
    CHU Clermont Ferrand, University of Auvergne, EA 7280, Clermont Ferrand, France Fondation FondaMental, Creteil, France Electronic address
    Schizophr Res 178:1-5. 2016
    ..To investigate the interest in the attitudes toward antipsychotic medication in exploring medication non-adherence...
  4. doi request reprint [Aripiprazole long-acting for the maintenance treatment of schizophrenia.]
    L Samalin
    Service de Psychiatrie B, CHU de Clermont Ferrand, EA 7280, Universite d Auvergne, 58, rue Montalembert, 63000 Clermont Ferrand, France Electronic address
    Encephale 40:487-494. 2014
    ..As mentioned in various professional recommendations, long-acting injectable antipsychotics, so long-acting injectable aripiprazole, are one of the major strategies of the maintenance treatment for patients with schizophrenia...
  5. pmc Patient perspectives on use of long-acting antipsychotics in bipolar disorder: focus on risperidone injection
    L Samalin
    Centre Hospitalier Universitaire, Clermont Ferrand, France
    Patient Prefer Adherence 4:325-34. 2010
    ..Long-acting second-generation antipsychotics in bipolar patients are therefore associated with long-term benefits, but their use in clinical practice needs to be improved...
  6. doi request reprint Residual symptoms and functional performance in a large sample of euthymic bipolar patients in France (the OPTHYMUM study)
    Ludovic Samalin
    CHU Clermont Ferrand, EA7280, Auvergne University, Clermont Ferrand, France Electronic address
    J Affect Disord 159:94-102. 2014
    ..We re-examined the functional influence of a large set of residual symptoms in 525 euthymic bipolar outpatients using self- and clinician-rated questionnaires (OPTHYMUM study)...
  7. pmc Guidelines for the use and management of long-acting injectable antipsychotics in serious mental illness
    Pierre Michel Llorca
    CHU Clermont Ferrand, EA 7280, Clermont Ferrand University, Clermont Ferrand, France
    BMC Psychiatry 13:340. 2013
    ..As part of a process to improve the quality of care, the French Association for Biological Psychiatry and Neuropsychopharmacology (AFPBN) elaborated guidelines for the use and management of antipsychotic depots in clinical practice...
  8. doi request reprint [French Society for Biological Psychiatry and Neuropsychopharmacology task force: Formal Consensus for the prescription of depot antipsychotics]
    L Samalin
    CHU Clermont Ferrand, EA U7280, Universite d Auvergne, Clermont Ferrand, France Electronic address
    Encephale 39:189-203. 2013
    ....
  9. doi request reprint Clinicians' attitudes toward the use of long-acting injectable antipsychotics
    Ludovic Samalin
    Department of Psychiatry B, University of Auvergne, Clermont Ferrand, France
    J Nerv Ment Dis 201:553-9. 2013
    ..Conversely, some attitudes related to organizational aspects, particularly the relevance of health care costs, may vary from one country to another. ..
  10. doi request reprint Methodological differences between pharmacological treatment guidelines for bipolar disorder: what to do for the clinicians?
    Ludovic Samalin
    Department of Adult Psychiatry B, CHU Clermont Ferrand, 58 rue Montalembert, 63000 Clermont Ferrand, France
    Compr Psychiatry 54:309-20. 2013
    ..The aim of this article is to underline the main differences between consensus-based guidelines (CBG) and evidence-based guidelines (EBG) currently available for the management of bipolar disorder...
  11. doi request reprint [Asenapine in bipolar disorder: efficacy, safety and place in clinical practice]
    L Samalin
    CMP B, CHU de Clermont Ferrand, Universite d Auvergne, 58, rue Montalembert, 63000 Clermont Ferrand, France
    Encephale 38:257-65. 2012
    ..Other therapeutic perspectives of asenapine are being assessed, in particular in specific population (pediatric and elderly patients)...
  12. doi request reprint [Methodological approach to inter "guideline" variability in the management of bipolar disorders]
    L Samalin
    Service de Psychiatrie, Centre Medico Psychologique B, CHU de Clermont Ferrand, BP 69, 63003 Clermont Ferrand Cedex 1, France
    Encephale 38:126-32. 2012
    ..In this context, tools have been developed for making medical decisions in the management of bipolar disorder: guidelines...
  13. doi request reprint [Lithium and anticonvulsants in bipolar depression]
    L Samalin
    CHU Clermont Ferrand, BP 69, Clermont Ferrand cedex 01, France
    Encephale 37:S203-8. 2011
    ..The different safety/efficacy ratios of mood stabilizers underlie the complementarity and the importance of combination between them, or with some second-generation antipsychotics, in the treatment of patients with bipolar disorder...
  14. doi request reprint [Guidelines for the biological treatment of bipolar depression]
    L Samalin
    CHU Clermont Ferrand, BP 69, Clermont Ferrand cedex 01, France
    Encephale 37:S218-23. 2011
    ..The development of second-generation antipsychotics in bipolar depression is an interesting development for our therapeutic armamentarium and has been incorporated in recent guidelines...
  15. doi request reprint Adherence to guidelines by French psychiatrists in their real world of clinical practice
    Ludovic Samalin
    Centre Hospitalier Universitaire, Clermont Ferrand, France
    J Nerv Ment Dis 199:239-43. 2011
    ..Guidelines for treatment of bipolar disorder are not frequently used. French psychiatrists' age and practice type are the most important variables correlated to the level of use of guidelines...
  16. doi request reprint Residual symptoms and specific functional impairments in euthymic patients with bipolar disorder
    Ludovic Samalin
    CHU Clermont Ferrand, University of Auvergne, Clermont Ferrand, France
    Bipolar Disord 18:164-73. 2016
    ....
  17. doi request reprint Patients' perspectives on residual symptoms in bipolar disorder: a focus group study
    Ludovic Samalin
    CHU Clermont Ferrand, Auvergne University, Clermont Ferrand CHU Saint Louis Lariboisière, Paris INSERM U955, Créteil Fondation FondaMental, Créteil CHU Pasteur, Nice CRHU Tours, INSERM U930, Francois Rabelais University, Tours CHRU Montpellier, Inserm U1061, Montpellier University, Montpellier Otsuka Pharmaceuticals France SAS, Rueil Malmaison and Bristol Myers Squibb, Rueil Malmaison, France
    J Nerv Ment Dis 202:550-5. 2014
    ..Bipolar patients experienced bipolar disorder as a chronic disorder because they frequently continued to suffer from RSs associated with a functional impact. ..
  18. doi request reprint Olanzapine pamoate for the treatment of schizophrenia--a safety evaluation
    Ludovic Samalin
    a CHU Clermont Ferrand, University of Auvergne, Clermont Ferrand, France
    Expert Opin Drug Saf 15:403-11. 2016
    ..Due to the type of sustained-release mechanism, olanzapine pamoate (OLAI) can differ in safety as compared with oral olanzapine. Recent safety data concerning olanzapine pamoate required an update of previous systematic reviews...
  19. doi request reprint Mood stabilizers and antipsychotics during breastfeeding: Focus on bipolar disorder
    Isabella Pacchiarotti
    Hospital Clinic, Institute of Neuroscience, University of Barcelona, IDIBAPS, CIBERSAM, Barcelona, Catalonia, Spain
    Eur Neuropsychopharmacol 26:1562-78. 2016
    ..Clozapine and amisulpiride are currently contraindicated. Long-term outcome studies evaluating the infant׳s health and psychosocial and cognitive functioning are needed. ..
  20. doi request reprint [Mixed states]
    Pierre Michel Llorca
    CHU Clermont Ferrand, BP 69, Clermont Ferrand cedex 01, France
    Encephale 38:S179-85. 2012
    ..As the evolution, the prognosis or the therapeutic strategies differ from what is applied in other thymic episodes, this transition from "mixed state" to manic or depressive episodes "with mixed features" may be relevant in practice...
  21. doi request reprint A composite scale applied to evaluate anxiety in schizophrenic patients (SAES)
    Pierre Michel Llorca
    CHU of Clermont Ferrand, Psychiatry Service, Place Henri Dunant, 63000, Clermont Ferrand, France
    Eur Arch Psychiatry Clin Neurosci 264:171-8. 2014
    ..The SAES can be useful to investigate clinical, psychopathological, and therapeutic aspects of anxiety in schizophrenia. ..
  22. doi request reprint Management of inter-episodic periods in patients with bipolar disorder
    Ludovic Samalin
    a Bipolar Disorder Unit, Institute of Neuroscience, Hospital Clinic, University of Barcelona, IDIBAPS, CIBERSAM, Barcelona, Spain
    Expert Rev Neurother 16:659-70. 2016
    ..This article critically reviews recently published clinical guidelines on the management of BD patients during the inter-episodic phases of illness, in order to highlight the consensual or controversial recommendations. ..
  23. doi request reprint Influence of lithium on sleep and chronotypes in remitted patients with bipolar disorder
    Pierre Alexis Geoffroy
    INSERM, U1144, Paris F 75006, France Université Paris Descartes, UMR S 1144, Paris F 75006, France Université Paris Diderot, Sorbonne Paris Cité, UMR S 1144, Paris F 75013, France AP HP, GH Saint Louis Lariboisière F Widal, Département de Psychiatrie et de Médecine Addictologique, 75475 Paris Cedex 10, France Fondation FondaMental, Creteil, France Electronic address
    J Affect Disord 204:32-9. 2016
    ..Although the chronobiological action of Li is well documented in animals, its effects on sleep and chronotypes in remitted BD patients have never been investigated...
  24. doi request reprint What is the evidence for the use of second-generation antipsychotic long-acting injectables as maintenance treatment in bipolar disorder?
    Ludovic Samalin
    Department of Psychiatry B, University of Auvergne, 63000 Clermont Ferrand, France
    Nord J Psychiatry 68:227-35. 2014
    ..In recent years, the use of second-generation antipsychotics long-acting injectable in the maintenance treatment of bipolar disorder has sparked interest in improving adherence and reducing the risk of relapse...
  25. pmc Management of bipolar disorder in the intercontinental region: an international, multicenter, non-interventional, cross-sectional study in real-life conditions
    Ludovic Samalin
    CHU Clermont Ferrand, EA7280, University of Auvergne, Clermont Ferrand, France
    Sci Rep 6:25920. 2016
    ..Clinical decision-making appears to be based on a multidimensional approach related to current symptomatology and type of bipolar disorder. ..
  26. doi request reprint Quetiapine extended release for the treatment of bipolar disorder
    Ludovic Samalin
    Centre Hospitalier Universitaire, Clermont Ferrand, Adult Psychiatry B, Auvergne University, EA 7280, Clermont Ferrand, France
    Expert Rev Neurother 14:987-1005. 2014
    ..This article provides an update of recent data on the efficacy and safety of quetiapine XR for the treatment of BD. ..
  27. pmc Asenapine in bipolar I disorder: evidence and place in patient management
    Ludovic Samalin
    centre hospitalier universitaire de Clermont Ferrand, Psychiatry B, 58, rue Montalembert, Clermont Ferrand 63000, France
    Ther Adv Chronic Dis 4:5-14. 2013
    ..This tolerability profile confirms the heterogeneity of the second-generation antipsychotic class and supports the view of some authors for the need to re-evaluate the boundaries of this group...